ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter of 2024. The dividend is payable on Jan. 3, to all shareholders of record as of Dec. 20. At the […]
Already an Subcriber? Log in
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter of 2024.
The dividend is payable on Jan. 3, to all shareholders of record as of Dec. 20. At the company’s current stock price, the payment yields about 1.2 percent on an annual basis.
ConMed is a medical technology company that provides devices and equipment for minimally invasive surgical procedures. The firm’s products are used by surgeons and other health-care professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
Headquartered in Largo, Florida since 2021, ConMed still operates a facility in New Hartford, where it was formerly headquartered.